|
Volumn 21, Issue 1, 2011, Pages 245-249
|
The first synthesis of [11C]SB-216763, a new potential PET agent for imaging of glycogen synthase kinase-3 (GSK-3)
|
Author keywords
11C SB 216763; Alzheimer's disease; Cancer; Glycogen synthase kinase 3 (GSK 3); Positron emission tomography (PET); Radiosynthesis
|
Indexed keywords
(3 (2,4 DICHLOROPHENYL) 4 (1 [11C]METHYL 1H INDOL 3 YL) 1H PYRROLE 2,5 DIONE);
2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE;
GLYCOGEN SYNTHASE KINASE 3;
GLYCOGEN SYNTHASE KINASE 3 INHIBITOR;
MALEIC ANHYDRIDE;
MALEIMIDE;
UNCLASSIFIED DRUG;
ARTICLE;
DRUG STRUCTURE;
DRUG SYNTHESIS;
IMAGING SYSTEM;
POSITRON EMISSION TOMOGRAPHY;
CARBON RADIOISOTOPES;
GLYCOGEN SYNTHASE KINASE 3;
INDOLES;
MALEIMIDES;
POSITRON-EMISSION TOMOGRAPHY;
PROTEIN KINASE INHIBITORS;
RADIOPHARMACEUTICALS;
|
EID: 78650522701
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2010.11.026 Document Type: Article |
Times cited : (36)
|
References (23)
|